version: English | 中文版
Custom Peptides
Hot Products
Catalog Peptides

Bone Gla Proteins

Peptide Name

CAT#

Peptide Sequence

Bone Gla Protein (45-49)

1931-1-1

Phe-Tyr-Gly-Pro-Val

Bone Gla Protein (45-49)

1931-1-2

Phe-Tyr-Gly-Pro-Val

Myelopeptide-2 (MP-2)

1931-1-3

Leu-Val-Val-Tyr-Pro-Trp

Myelopeptide-2 (MP-2)

1931-1-4

Leu-Val-Val-Tyr-Pro-Trp

Osteocalcin (1-49), human

1931-1-5

Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Gla-Pro-Arg-Arg-Gla-Val-Cys-Gla-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val

Osteocalcin (37-49), human

1931-1-6

Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val

Osteocalcin (37-49), human

1931-1-7

Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val

Osteocalcin (7-19) (human)

1931-1-8

Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Glu-Pro-Arg

Osteocalcin (7-19) (human)

1931-1-9

Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Glu-Pro-Arg

Osteocalcin 30-43 Fragment

1931-1-10

Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg

Osteocalcin 30-43 Fragment

1931-1-11

Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg

[Tyr38, Phe42,46] Bone Gla Protein

1931-1-12

Tyr-Gln-Glu-Ala-Phe-Arg-Arg-Phe-Phe-Gly-Pro-Val

 

 

  •   after months’ research, we have developed helical peptide. The building blocks of helical peptide are 2 amino acides modified with pentenyls, butenyls or allyls in the sequence... (2011.3.25)
  •  with the rapid increase of sales amount, the current production capacity could not satisfy our customer’s needs...(2011.3.20)
  • More...
  • ChinaPeptides Co.,Ltd.
    For any inquiries, please contact

    Marketing outside of China
    Tel: +86-21-50790349
    Fax: +86-21-50795570
    Mail: outside@chinapeptides.com

    Marketing inside of china
    Tel: +86-21-50795728
            +86-21-50792270
            +86-21-50792271
    Fax: +86-21-50795570
    Mail: inside@chinapeptides.com
Contact     |    Jobs    |    About Us     |    My Account    |    Downloads
COPYRIGHT © 2009 CHINAPEPTIDES CORPORATION. ALL RIGHTS RESERVED